Centiva Capital’s Insmed INSM Stock Holding History

Centiva Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$174K	–	1846
2025 Q4	$174K	Sell	1,000 -47,000	-98%	-$8.58M	﹤0.01%	1010
2025 Q3	$6.91M	Sell	48,000 -2,000	-4%	-$245K	0.07%	193
2025 Q2	$5.03M	Buy	+50,000	New	+$3.82M	0.08%	140

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Centiva Capital's INSM Position: Q2 2026 in Review

Centiva Capital sold out of Insmed (INSM) in Q2 2026, closing a stake of 2,347 shares — an estimated $384K sold.

Centiva Capital first reported a position in INSM in Q4 2020 and held it in 6 quarters. The position peaked at $384K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Centiva Capital reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 2,347 Insmed shares in Q2 2026, an estimated $384K.
Centiva Capital first reported a position in Insmed in Q4 2020 and held it in 6 quarters.
Centiva Capital's Insmed position peaked at $384K in Q1 2026.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.